Institutional Ownership Pmv Pharmaceuticals, Inc. (PMVP)
This table provides information about the institutional ownership of Pmv Pharmaceuticals, Inc. (PMVP). We have compiled data on the 62 institutions that hold shares in the stock, with a total of 40.4 Million shares, which have been reported (via 13F filing form) to have a value of $54.1 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
152,283
shares
|
$193,399
0.0% of portfolio
|
Q1 2025
Reduced 44.72%
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
May 15, 2025 Q1 2025 |
148,800
shares
|
$188,976
0.0% of portfolio
|
Q1 2025
Reduced 26.37%
|
|
|
Evoke Wealth, LLC
|
May 13, 2025 Q1 2025 |
133,122
shares
|
$169,064
0.0% of portfolio
|
Q3 2024
Added 110.53%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
May 15, 2025 Q1 2025 |
129,914
shares
|
$164,990
0.0% of portfolio
|
Q1 2025
Reduced 75.94%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 13, 2025 Q1 2025 |
126,004
shares
|
$160,025
0.0% of portfolio
|
Q2 2024
Reduced 53.82%
|
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
107,346
shares
|
$136,329
0.0% of portfolio
|
Q1 2025
Added 0.01%
|
|
|
Walleye Capital LLC
Plymouth, MN |
May 14, 2025 Q1 2025 |
101,696
shares
|
$129,153
0.0% of portfolio
|
Q1 2025
Reduced 20.32%
|
|
|
Adar1 Capital Management, LLC
Austin, TX |
May 15, 2025 Q1 2025 |
101,008
shares
|
$128,280
0.02% of portfolio
|
Q3 2024
Added 102.02%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Jun 26, 2025 Q1 2025 |
90,263
shares
|
$114,634
0.0% of portfolio
|
Q1 2025
Reduced 25.55%
|
|
|
Panagora Asset Management Inc
Boston, MA |
May 15, 2025 Q1 2025 |
89,631
shares
|
$113,831
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Pnc Financial Services Group, Inc.
Pittsburgh, PA |
May 09, 2025 Q1 2025 |
62,134
shares
|
$78,910
0.0% of portfolio
|
Q1 2025
Reduced 10.1%
|
|
|
Velan Capital Investment Management LP
Alpharetta, GA |
May 15, 2025 Q1 2025 |
35,000
shares
|
$44,450
0.07% of portfolio
|
Q4 2024
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
34,706
shares
|
$44,076
0.0% of portfolio
|
Q1 2025
Reduced 22.13%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 14, 2025 Q1 2025 |
33,600
shares
|
$42,672
0.0% of portfolio
|
Q2 2024
Reduced 21.5%
|
|
|
Hsbc Holdings PLC
London, X0 |
May 14, 2025 Q1 2025 |
30,891
shares
|
$39,231
0.0% of portfolio
|
Q1 2025
Reduced 20.95%
|
|
|
Barclays PLC
London, X0 |
May 15, 2025 Q1 2025 |
30,197
shares
|
$38,350
0.0% of portfolio
|
Q4 2024
Reduced 0.17%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
28,066
shares
|
$35,643
0.0% of portfolio
|
Q1 2025
Reduced 32.8%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
May 15, 2025 Q1 2025 |
22,900
shares
|
$29,083
0.0% of portfolio
|
Q1 2025
Reduced 34.94%
|
|
|
Squarepoint Ops LLC
New York, NY |
May 15, 2025 Q1 2025 |
21,896
shares
|
$27,807
0.0% of portfolio
|
Q1 2025
Reduced 70.01%
|
|
|
Citigroup Inc
|
May 12, 2025 Q1 2025 |
19,310
shares
|
$24,523
0.0% of portfolio
|
Q1 2025
Reduced 96.25%
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
May 14, 2025 Q1 2025 |
18,007
shares
|
$22,868
0.0% of portfolio
|
Q1 2025
Reduced 21.05%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
14,120
shares
|
$17,932
0.0% of portfolio
|
Q1 2025
Reduced 86.91%
|
|
|
Independent Advisor Alliance
|
May 12, 2025 Q1 2025 |
12,500
shares
|
$15,875
0.0% of portfolio
|
Q1 2025
Reduced 0.11%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
11,449
shares
|
$14,540
0.0% of portfolio
|
Q1 2025
Reduced 53.44%
|
|
|
Group One Trading, L.P.
Chicago, IL |
May 14, 2025 Q1 2025 |
11,296
shares
|
$14,345
0.0% of portfolio
|
Q1 2025
Reduced 24.61%
|